Literature DB >> 8112858

Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

C Wennerås1, A M Svennerholm, C Czerkinsky.   

Abstract

We have examined whether oral immunization of adult Swedish volunteers with a prototype enterotoxigenic Escherichia coli vaccine would induce antigen-specific T-cell responses in blood. Volunteers were given one to three doses of the whole-cell component of the vaccine, which consisted of formalin-inactivated bacteria expressing the fimbrial colonization factor antigens I and II. Following immunization, in vitro stimulation of blood mononuclear cells with the colonization factor antigens resulted in modest proliferative responses which were accounted for mainly by CD4+ T cells and, to a lesser extent, by CD8+ T cells. A main finding of this study was that a majority of the orally immunized volunteers had circulating T cells capable of producing large quantities of gamma interferon following in vitro exposure to either of the colonization factor antigens. No interleukin 2 production could be detected in the cell cultures. These results suggest that oral immunization of humans induces the migration of specific mucosal T immunocytes from the intestine into peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112858      PMCID: PMC186196          DOI: 10.1128/iai.62.3.874-879.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  C Wennerås; A M Svennerholm; C Ahrén; C Czerkinsky
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  The gut-associated lymphoid system: nature and properties of the large dividing cells.

Authors:  D Guy-Grand; C Griscelli; P Vassalli
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

6.  Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors:  P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

7.  Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigen.

Authors:  J Katz; S M Michalek; K W Beagley; J H Eldridge
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

8.  In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women.

Authors:  Y P Huang; J C Pechere; M Michel; L Gauthey; M Loreto; J A Curran; J P Michel
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

9.  Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.

Authors:  C Ahrén; C Wennerås; J Holmgren; A M Svennerholm
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

10.  The origin and antigen-dependent distribution of IgA-containing cells in the intestine.

Authors:  A J Husband; J L Gowans
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  9 in total

1.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.

Authors:  N Toida; G Hajishengallis; H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.

Authors:  M Quiding-Järbrink; I Ahlstedt; C Lindholm; E L Johansson; H Lönroth
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.

Authors:  C Wennerås; F Qadri; P K Bardhan; R B Sack; A M Svennerholm
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.

Authors:  B Samuel Lundin; Camilla Johansson; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.

Authors:  E M Nilsen; K E Lundin; P Krajci; H Scott; L M Sollid; P Brandtzaeg
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

7.  Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.

Authors:  Monica A McArthur; Wilbur H Chen; Laurence Magder; Myron M Levine; Marcelo B Sztein
Journal:  PLoS Negl Trop Dis       Date:  2017-01-19

8.  Cellular and Mucosal Immune Responses Following Vaccination with Inactivated Mutant of Escherichia coli O157:H7.

Authors:  Robert G Schaut; Paola M Boggiatto; Crystal L Loving; Vijay K Sharma
Journal:  Sci Rep       Date:  2019-04-22       Impact factor: 4.379

9.  Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice.

Authors:  S Baqar; L A Applebee; A L Bourgeois
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.